483
Catalent Maryland, Inc.Catalent Maryland, Inc. – FDA 483, Apr 9, 2025
Record Details
An FDA inspection of Catalent Maryland, Inc. in Baltimore, MD, a biological drug product manufacturer, revealed two significant observations. The firm failed to follow procedures designed to prevent microbiological contamination during sterile filling operations and did not maintain its manufacturing buildings in a good state of repair, specifically noting floor damage in a critical area. These issues indicate potential risks to the sterility and quality of drug products.
View Company Profile
ID · 6364cf7a-9c9e-4c45-91b6-3878217bd57b
Other documents for Catalent Maryland, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.